Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
México
79
Veracruz
79
Historia
51
poesía
48
Mexico
41
literatura
41
Literatura
38
reseña
37
educación superior
32
Xalapa
30
ensayo
30
higher education
28
Reseña
25
música
25
siglo XX
25
Argentina
24
COVID-19
23
China
23
traducción
23
Bibliometrics
22
Educación
22
Educación superior
21
Mujeres
21
Violencia
21
memoria
21
Bibliometría
20
España
20
Estado
18
Porfiriato
18
educación
18
-
24821por Moussa, Abdou Kadri, Lukulunga, Loubet Unyendje, Mahfoud, Mustapha, El Bardouni, Ahmed, Ismail, Farid, Kharmaz, Mohamed, Berrada, Mohammed Saleh, El Yaacoubi, Moradh“…En per-opératoire nous avons enregistré deux (02) cas de fractures du plateau tibial médial, en post-opératoire on a eu 1 cas d'infection superficielle et comme complications tardives une raideur du genou (18,2%) et 3,4% de pseudarthrose, une récidive du génu varum dans 19,1% (n = 22) après 3 années de recul. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24822por Ruane, Peter, Buggisch, Peter, Moreno, ANA, Isakov, Vasily, Backus, Lisa, Ain, Dani, Gonzalez-Garcia, Juan, Naik, Sarjita, Mehta, Swarup, Lee, Jina, Llewellyn, Joe, Mertens, Michael, Natha, Macky, Osinusi, Anu, Slim, Jihad, Zhdanov, Konstantin, Berenguer, Juan, Zeuzem, Stefan“…CONCLUSION: This analysis of diverse cohorts from the EU and US yielded high SVR rates similar to SVR rates seen in multiple RW monoinfected cohorts and supports the use of 8 weeks of LDV/SOF in TN, NC GT 1 HIV/HCV coinfected patients with a baseline HCV viral load < 6 million. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24823por Lu, Ing Ni, Kulkarni, Spoorthy, Fisk, Marie, Kostapanos, Michalis, Banham-Hall, Edward, Kadyan, Sonakshi, Bond, Simon, Norton, Sam, Cope, Andrew, Galloway, James, Hall, Frances, Jayne, David, Wilkinson, Ian B., Cheriyan, Joseph“…TRIAL REGISTRATION: Registered on EU Clinical Trials Register EudraCT Number: 2020-002229-27 registered: 9 June 2020. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24824por Li, You, Wang, Xin, Blau, Dianna M, Caballero, Mauricio T, Feikin, Daniel R, Gill, Christopher J, Madhi, Shabir A, Omer, Saad B, Simões, Eric A F, Campbell, Harry, Pariente, Ana Bermejo, Bardach, Darmaa, Bassat, Quique, Casalegno, Jean-Sebastien, Chakhunashvili, Giorgi, Crawford, Nigel, Danilenko, Daria, Do, Lien Anh Ha, Echavarria, Marcela, Gentile, Angela, Gordon, Aubree, Heikkinen, Terho, Huang, Q Sue, Jullien, Sophie, Krishnan, Anand, Lopez, Eduardo Luis, Markić, Joško, Mira-Iglesias, Ainara, Moore, Hannah C, Moyes, Jocelyn, Mwananyanda, Lawrence, Nokes, D James, Noordeen, Faseeha, Obodai, Evangeline, Palani, Nandhini, Romero, Candice, Salimi, Vahid, Satav, Ashish, Seo, Euri, Shchomak, Zakhar, Singleton, Rosalyn, Stolyarov, Kirill, KStoszek, Sonia, von Gottberg, Anne, Wurzel, Danielle, Yoshida, Lay-Myint, Yung, Chee Fu, Zar, Heather J, Nair, Harish“…RSV passive immunisation programmes targeting protection during the first 6 months of life could have a substantial effect on reducing RSV disease burden, although more data are needed to understand the implications of the potential age-shifts in peak RSV burden to older age when these are implemented. FUNDING: EU Innovative Medicines Initiative Respiratory Syncytial Virus Consortium in Europe (RESCEU).…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24825por Aman, Jurjan, Duijvelaar, Erik, Botros, Liza, Kianzad, Azar, Schippers, Job R, Smeele, Patrick J, Azhang, Sara, Bartelink, Imke H, Bayoumy, Ahmed A, Bet, Pierre M, Boersma, Wim, Bonta, Peter I, Boomars, Karin A T, Bos, Lieuwe D J, van Bragt, Job J M H, Braunstahl, Gert-Jan, Celant, Lucas R, Eger, Katrien A B, Geelhoed, J J Miranda, van Glabbeek, Yurika L E, Grotjohan, Hans P, Hagens, Laura A, Happe, Chris M, Hazes, Boaz D, Heunks, Leo M A, van den Heuvel, Michel, Hoefsloot, Wouter, Hoek, Rianne J A, Hoekstra, Romke, Hofstee, Herman M A, Juffermans, Nicole P, Kemper, E Marleen, Kos, Renate, Kunst, Peter W A, Lammers, Ariana, van der Lee, Ivo, van der Lee, E Laurien, Maitland-van der Zee, Anke-Hilse, Mau Asam, Pearl F M, Mieras, Adinda, Muller, Mirte, Neefjes, Elisabeth C W, Nossent, Esther J, Oswald, Laurien M A, Overbeek, Maria J, Pamplona, Carolina C, Paternotte, Nienke, Pronk, Niels, de Raaf, Michiel A, van Raaij, Bas F M, Reijrink, Merlijn, Schultz, Marcus J, Serpa Neto, Ary, Slob, Elise M A, Smeenk, Frank W J M, Smit, Marry R, Smits, A Josien, Stalenhoef, Janneke E, Tuinman, Pieter R, Vanhove, Arthur L E M, Wessels, Jeroen N, van Wezenbeek, Jessie C C, Vonk Noordegraaf, Anton, de Man, Frances S, Bogaard, Harm J“…This study is registered with the EU Clinical Trials Register (EudraCT 2020–001236–10). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24826por Jerbi, Z., Arfaoui, B., Gueddich, N.N., Boussetta, N., Ajili, F., Ben Abdelhafidh, N., Louzir, B.“…RÉSULTATS: Nous avons colligé 300 patients ; 63 ont eu un dosage de l’interleukine 6, soit 21 %. L’âge moyen de la population incluse était de 63 ans avec une prédominance féminine soit un sex-ratio de 2,15. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24827por Cantarel, C., Richez, B., Durrieu, F., Pernot, S., Chakiba, C., Soubeyran, I., Bellera, C., Mathoulin-Pélissier, S.“…Parmi les 55 sujets ayant eu une sérologie positive en cours d’étude, 18 (33 %) ne reportaient pas de précédente infection connue au SARS-COV-2 et 27 (49 %) n'ont déclaré aucun contact avec une personne présentant des symptômes d'infection. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24828“…En moyenne les patients ont eu 2,6 visites et 48 % d'entre eux ont un suivi de plus de 12 mois. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24829“…The levels of blood glucose, insulin, C-peptide, cortisol and ammonia were 35 mg/dL, <img src="data: image/png;base64,iVBORw0KGgoAAAANSUhEUgAAACMAAAARCAIAAADYCYKoAAAAAXNSR0IArs4c6QAAAAlwSFlzAAAOxAAADsQBlSsOGwAAAMBJREFUSEvdVcENwyAMhI5l9sHrhE36gg0yAcojsAt1EmhIZQVFVfLAL3w6Y+t8CJlSEo/E65EuS5OeO0VnUKE7asmCNaVJqMikXnSIGObJjxXOgscmTNXp0sl7a4QBhLYlOwNrDlv1c0lOb3JENErmXTiUysS+vXf/A764JxK96N+czc+0nejePjNX22kodQB6CJsXGTBZLYpDecJuWgC6FLQNSw0dBG/Jf1FyP2wTf+Oiek3JdsI4hQNbdvhrfACYFi2Z8Bo2twAAAABJRU5ErkJggg==">U/mL, 2.9 ng/mL, 18.5 ug/dL and 40.4 ug/dL, respectively. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24830“…CONTEXTE: Les pratiques liées à la télémédecine ont eu un essor considérable au cours de l'épidémie de la COVID-19. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24831por Ruyssen-Witrand, A., Dimeglio, C., Nogué, E., Molinari, N., Pham, T., Constantin, A., Gaujoux-Viala, C., Miceli Richard, C., Fogel, O., Herin, F., Martin-Blondel, G., Balandraud, N., Berenbaum, F., Breuil, V., Chary-Valckenaere, I., Confavreux, C., Devauchelle Pensec, V., Fautrel, B., Flipo, R.M., Mulleman, D., Tournadre, A., Truchetet, M.E., Vittecoq, O., Izopet, J., Morel, J.“…Les 14 patients RIC ayant eu une forme sévère de COVID-19 (nécessité d’une oxygénothérapie) avaient des taux d’Igtot plus élevés (taux médian chez les 14 RIC avec COVID sévère : 374,7 BAU [EIQ : 155,3–916,8) versus 122,1 [EIQ : 6,6–304,7], p < 0,01). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24832por Thomas, M., Masson, M., Bitoun, S., Barnetche, T., Seror, R., Lazaro, E., Richez, C., Allanore, Y., Avouac, J.“…L’ensemble des infections COVID-19 ont été non sévères, aucun patient ayant eu recours à une hospitalisation ou à une oxygénothérapie. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24833
-
24834por Stahl, A, Wiebusch, C, Guler, A M, Kamiscioglu, M, Sever, R, Yilmazer, A U, Gunes, C, Yilmaz, D, Del Amo Sanchez, P, Duchesneau, D, Pessard, H, Marcoulaki, E, Papazoglou, I A, Berardi, V, Cafagna, F, Catanesi, M G, Magaletti, L, Mercadante, A, Quinto, M, Radicioni, E, Ereditato, A, Kreslo, I, Pistillo, C, Weber, M, Ariga, A, Ariga, T, Strauss, T, Hierholzer, M, Kawada, J, Hsu, C, Haug, S, Jipa, A, Lazanu, I, Cardini, A, Lai, A, Oldeman, R, Thomson, M, Blake, A, Prest, M, Auld, A, Elliot, J, Lumbard, J, Thompson, C, Gornushkin, Y A, Pascoli, S, Collins, R, Haworth, M, Thompson, J, Bencivenni, G, Domenici, D, Longhin, A, Blondel, A, Bravar, A, Dufour, F, Karadzhov, Y, Korzenev, A, Noah, E, Ravonel, M, Rayner, M, Asfandiyarov, R, Haesler, A, Martin, C, Scantamburlo, E, Cadoux, F, Bayes, R, Soler, F J P, Aalto-Setälä, L, Enqvist, K, Huitu, K, Rummukainen, K, Nuijten, G, Eskola, K J, Kainulainen, K, Kalliokoski, T, Kumpulainen, J, Loo, K, Maalampi, J, Manninen, M, Moore, I, Suhonen, J, Trzaska, W H, Tuominen, K, Virtanen, A, Bertram, I, Finch, A, Grant, N, Kormos, L L, Ratoff, P, Christodoulou, G, Coleman, J, Touramanis, C, Mavrokoridis, K, Murdoch, M, McCauley, N, Payne, D, Jonsson, P, Kaboth, A, Long, K, Malek, M, Scott, M, Uchida, Y, Wascko, M O, Di Lodovico, F, Wilson, J R, Still, B, Sacco, R, Terri, R, Campanelli, M, Nichol, R, Thomas, J, Izmaylov, A, Khabibullin, M, Khotjantsev, A, Kudenko, Y, Matveev, V, Mineev, O, Yershov, N, Palladino, V, Evans, J, Söldner-Rembold, S, Yang, U K, Bonesini, M, Pihlajaniemi, T, Weckström, M, Mursula, K, Enqvist, T, Kuusiniemi, P, Räihä, T, Sarkamo, J, Slupecki, M, Hissa, J, Kokko, E, Aittola, M, Barr, G, Haigh, M D, de Jong, J, O'Keeffe, H, Vacheret, A, Weber, A, Galvanin, G, Temussi, M, Caretta, O, Davenne, T, Densham, C, Ilic, J, Loveridge, P, Odell, J, Wark, D, Robert, A, Andrieu, B, Popov, B, Giganti, C, Levy, J -M, Dumarchez, J, Buizza-Avanzini, M, Cabrera, A, Dawson, J, Franco, D, Kryn, D, Obolensky, M, Patzak, T, Tonazzo, A, Vanucci, F, Orestano, D, Di Micco, B, Tortora, L, Bésida, O, Delbart, A, Emery, S, Galymov, V, Mazzucato, E, Vasseur, G, Zito, M, Kudryavtsev, V A, Thompson, L F, Tsenov, R, Kolev, D, Rusinov, I, Bogomilov, M, Vankova, G, Matev, R, Vorobyev, A, Novikov, Yu, Kosyanenko, S, Suvorov, V, Gavrilov, G, Baussan, E, Dracos, M, Jollet, C, Meregaglia, A, Vallazza, E, Agarwalla, S K, Li, T, Autiero, D, Chaussard, L, Déclais, Y, Marteau, J, Pennacchio, E, Rondio, E, Lagoda, J, Zalipska, J, Przewlocki, P, Grzelak, K, Barker, G J, Boyd, S, Harrison, P F, Litchfield, R P, Ramachers, Y, Badertscher, A, Curioni, A, Degunda, U, Epprecht, L, Gendotti, A, Knecht, L, Di Luise, S, Horikawa, S, Lussi, D, Murphy, S, Natterer, G, Petrolo, F, Periale, L, Rubbia, A, Sergiampietri, F, Viant, T“…Based on the expertise present at CERN and in European and in international research groups, and building upon the results of several years of EU-funded design studies, we are confident that the technology for the beam and detectors is sufficiently mature to allow for an early start to realizing the facility. …”
Publicado 2012
Enlace del recurso
-
24835por JAROSLAV KREMENEK, George“…I have helped to implement iRODS together with Fedora Commons and other tools at NKP in Prague Czech republic as a base for the EU funded digital library project. The system is now in a full production. …”
Publicado 2014
Enlace del recurso
-
24836por Biard, L., Pugnet, G., Cacciatore, C., Munia, I., Lansiaux, P., Le Maignan, C., Crichi, B., Urbain, F., Marjanovic, Z., Berthier, S., Rimar, D., Farge, D.“…Parmi les patients ACSHP, l’incidence cumulée de COVID-19 symptomatique à partir du 1(er) janvier 2021 fut de 8 % (IC95 % : 2–20), 14 % (IC95 % : 5–28) et 33 % (IC95 % : 18–49) à 6, 12 et 18 mois respectivement. Il n’y a eu aucun décès dû à une infection COVID-19 chez les témoins. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24837por Myers, Bronwyn, Williams, Petal Petersen, Govender, Rajen, Manderscheid, Ron, Koch, J. Randy“…Les pourvoyeurs soulignaient qu’un taux élevé d’attrition des patients, une variabilité dans la volonté d’implanter le système ainsi qu’une capacité limitée d’interpréter les rétroactions sur le rendement ont eu un impact sur l’ampleur de l’implantation du système. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24838Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseasespor Bousquet, J. Jean, Schünemann, Holger J., Togias, Alkis, Erhola, Marina, Hellings, Peter W., Zuberbier, Torsten, Agache, Ioana, Ansotegui, Ignacio J., Anto, Josep M., Bachert, Claus, Becker, Sven, Bedolla-Barajas, Martin, Bewick, Michael, Bosnic-Anticevich, Sinthia, Bosse, Isabelle, Boulet, Louis P., Bourrez, Jean Marc, Brusselle, Guy, Chavannes, Niels, Costa, Elisio, Cruz, Alvaro A., Czarlewski, Wienczyslawa, Fokkens, Wytske J., Fonseca, Joao A., Gaga, Mina, Haahtela, Tari, Illario, Maddalena, Klimek, Ludger, Kuna, Piotr, Kvedariene, Violeta, Le, L. T. T., Larenas-Linnemann, Desiree, Laune, Daniel, Lourenço, Olga M., Menditto, Enrica, Mullol, Joaquin, Okamoto, Yashitaka, Papadopoulos, Nikos, Pham-Thi, Nhân, Picard, Robert, Pinnock, Hilary, Roche, Nicolas, Roller-Wirnsberger, Regina E., Rolland, Christine, Samolinski, Boleslaw, Sheikh, Aziz, Toppila-Salmi, Sanna, Tsiligianni, Ioanna, Valiulis, Arunas, Valovirta, Erkka, Vasankari, Tuula, Ventura, Maria-Teresa, Walker, Samantha, Williams, Sian, Akdis, Cezmi A., Annesi-Maesano, Isabella, Arnavielhe, Sylvie, Basagana, Xavier, Bateman, Eric, Bedbrook, Anna, Bennoor, K. S., Benveniste, Samuel, Bergmann, Karl C., Bialek, Slawomir, Billo, Nils, Bindslev-Jensen, Carsten, Bjermer, Leif, Blain, Hubert, Bonini, Mateo, Bonniaud, Philippe, Bouchard, Jacques, Briedis, Vitalis, Brightling, Christofer E., Brozek, Jan, Buhl, Roland, Buonaiuto, Roland, Canonica, Giorgo W., Cardona, Victoria, Carriazo, Ana M., Carr, Warner, Cartier, Christine, Casale, Thomas, Cecchi, Lorenzo, Cepeda Sarabia, Alfonso M., Chkhartishvili, Eka, Chu, Derek K., Cingi, Cemal, Colgan, Elaine, de Sousa, Jaime Correia, Courbis, Anne Lise, Custovic, Adnan, Cvetkosvki, Biljana, D’Amato, Gennaro, da Silva, Jane, Dantas, Carina, Dokic, Dejand, Dauvilliers, Yves, Dedeu, Antoni, De Feo, Giulia, Devillier, Philippe, Di Capua, Stefania, Dykewickz, Marc, Dubakiene, Ruta, Ebisawa, Motohiro, El-Gamal, Yaya, Eller, Esben, Emuzyte, Regina, Farrell, John, Fink-Wagner, Antjie, Fiocchi, Alessandro, Fontaine, Jean F., Gemicioğlu, Bilun, Schmid-Grendelmeir, Peter, Gamkrelidze, Amiran, Garcia-Aymerich, Judith, Gomez, Maximiliano, González Diaz, Sandra, Gotua, Maia, Guldemond, Nick A., Guzmán, Maria-Antonieta, Hajjam, Jawad, O’B Hourihane, John, Humbert, Marc, Iaccarino, Guido, Ierodiakonou, Despo, Illario, Maddalena, Ivancevich, Juan C., Joos, Guy, Jung, Ki-Suck, Jutel, Marek, Kaidashev, Igor, Kalayci, Omer, Kardas, Przemyslaw, Keil, Thomas, Khaitov, Mussa, Khaltaev, Nikolai, Kleine-Tebbe, Jorg, Kowalski, Marek L., Kritikos, Vicky, Kull, Inger, Leonardini, Lisa, Lieberman, Philip, Lipworth, Brian, Lodrup Carlsen, Karin C., Loureiro, Claudia C., Louis, Renaud, Mair, Alpana, Marien, Gert, Mahboub, Bassam, Malva, Joao, Manning, Patrick, De Manuel Keenoy, Esteban, Marshall, Gailen D., Masjedi, Mohamed R., Maspero, Jorge F., Mathieu-Dupas, Eve, Matricardi, Poalo M., Melén, Eric, Melo-Gomes, Elisabete, Meltzer, Eli O., Menditto, Enrica, Mercier, Jacques, Miculinic, Neven, Mihaltan, Florin, Milenkovic, Branislava, Moda, Giuliana, Mogica-Martinez, Maria-Dolores, Mohammad, Yousser, Montefort, Steve, Monti, Ricardo, Morais-Almeida, Mario, Mösges, Ralf, Münter, Lars, Muraro, Antonella, Murray, Ruth, Naclerio, Robert, Napoli, Luigi, Namazova-Baranova, Leila, Neffen, Hugo, Nekam, Kristoff, Neou, Angelo, Novellino, Enrico, Nyembue, Dieudonné, O’Hehir, Robin, Ohta, Ken, Okubo, Kimi, Onorato, Gabrielle, Ouedraogo, Solange, Pali-Schöll, Isabella, Palkonen, Susanna, Panzner, Peter, Park, Hae-Sim, Pépin, Jean-Louis, Pereira, Ana-Maria, Pfaar, Oliver, Paulino, Ema, Phillips, Jim, Picard, Robert, Plavec, Davor, Popov, Ted A., Portejoie, Fabienne, Price, David, Prokopakis, Emmanuel P., Pugin, Benoit, Raciborski, Filip, Rajabian-Söderlund, Rojin, Reitsma, Sietze, Rodo, Xavier, Romano, Antonino, Rosario, Nelson, Rottem, Menahenm, Ryan, Dermot, Salimäki, Johanna, Sanchez-Borges, Mario M., Sisul, Juan-Carlos, Solé, Dirceu, Somekh, David, Sooronbaev, Talant, Sova, Milan, Spranger, Otto, Stellato, Cristina, Stelmach, Rafael, Suppli Ulrik, Charlotte, Thibaudon, Michel, To, Teresa, Todo-Bom, Ana, Tomazic, Peter V., Valero, Antonio A., Valenta, Rudolph, Valentin-Rostan, Marylin, van der Kleij, Rianne, Vandenplas, Olivier, Vezzani, Giorgio, Viart, Frédéric, Viegi, Giovanni, Wallace, Dana, Wagenmann, Martin, Wang, De Y., Waserman, Susan, Wickman, Magnus, Williams, Dennis M., Wong, Gary, Wroczynski, Piotr, Yiallouros, Panayiotis K., Yorgancioglu, Arzu, Yusuf, Osman M., Zar, Heahter J., Zeng, Stéphane, Zernotti, Mario, Zhang, Luo, Zhong, Nan S., Zidarn, Mihaela“…Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted “patient activation”, (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Santé as a Good Practice in the field of digitally-enabled, integrated, person-centred care. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24839por Saunders, Helen, Khan, Cass, D’Hooghe, Thomas, Magnúsdóttir, Thora Björg, Klingmann, Ingrid, Hrafnsdóttir, Sigrún“…The progesterone vaginal pessaries studied are now marketed as Cyclogest®, Amelgen®, Cyclovita®, Luteum and Cygest® throughout the EU, Asia and Middle East & North Africa. The competing interests are as follows. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24840Publicado 2012“…In 2000, Hemispherx Europe (Hemispherx) obtained orphan drug status for Ampligen® for the treatment of chronic fatigue syndrome in the EU, providing Hemispherx with 10 years of marketing exclusivity following the launch of the drug, as well as potential financial research benefits for the agent. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto